Cognition Therapeutics Inc (CGTX)

Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	12.24%7.74	8.82	13.67	6.38	13.98
Research and Development	16.72%5.10	6.12	11.15	3.77	11.48
Operating Income/Loss	12.24%-7.74	-8.82	-13.67	-6.38	-13.98
	13.96%-3.93	-4.57	-3.34	-4.93	-6.73
Attributable To Parent	13.96%-3.93	-4.57	-3.34	-4.93	-6.73
Basic Average Shares	1.61%90.62	89.19	-	77.95	63.69
Diluted Average Shares	1.61%90.62	89.19	-	77.95	63.69
Basic Earnings Per Share	20.00%-0.04	-0.05	-	-0.06	-0.11
Diluted Earnings Per Share	20.00%-0.04	-0.05	-	-0.06	-0.11